Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction by Valdes-Marquez, E, Clarke, R, Hill, M, Watkins, H, Hopewell, JC

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke by Hopewell, J, Malik, R, Valdes-Marquez, E, Worrall, B, Collins, R, METASTROKE Collaboration of the ISGC

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study by Clarke, R, Valdes-Marquez, E, Hill, M, Gordon, J, Farrall, M, Hamsten, A, Watkins, H, Hopewell, J

Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE)... by Haynes, R, Valdes-Marquez, E, Hopewell, JC, Chen, F, Li, J, Parish, S, Landray, MJ, Armitage, J, Hps2-Thrive Collaborative Group

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study by Parish, S, Hopewell, J, Hill, M, Marcovina, S, Valdes-Marquez, E, Haynes, R, Offer, A, Pedersen, T, Baigent, C, Collins, R, Landray, M, Armitage, J

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5M individuals by Camm, C, Lacey, B, Massa, M, Von Ende, A, Stiby, A, Gajendragadkar, P, Valdes Marquez, E, Lewington, S, Wijesurendra, R, Parish, S, Casadei, B, Hopewell, J

Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. by Li, J, Chen, Y, Li, X, Armitage, J, Feng, F, Liu, J, Gao, Y, Zhang, H, Zhang, D, Hundei, W, Chen, Z, Chen, F, Hopewell, J, Valdes-Marquez, E, Landray, M, Jiang, L

Genetic loci on chromosome 5 are associated with circulating levels of interleukin-5 and eosinophil count in a European population with high risk for cardiovascular disease by McLeod, O, Silveira, A, Valdes-Marquez, E, Björkbacka, H, Almgren, P, Gertow, K, Gådin, J, Bäcklund, A, Sennblad, B, Baldassarre, D, Veglia, F, Humphries, S, Tremoli, E, de Faire, U, Nilsson, J, Melander, O, Hopewell, J, Clarke, R, Björck, H, Hamsten, A, Öhrvik, J, Strawbridge, R

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease by Sammons, E, Hopewell, JC, Chen, F, Stevens, W, Wallendszus, K, Valdes-Marquez, E, Dayanandan, R, Knott, C, Murphy, K, Wincott, E, Baxter, A, Goodenough, R, Lay, M, Hill, M, Macdonnell, S, Fabbri, G, Lucci, D, Fajardo-Moser, M, Brenner, S, Hao, D, Zhang, H, Liu, J, Wuhan, B, Mosegaard, S, Herrington, W, Wanner, C, Angermann, C, Ertl, G, Maggioni, A, Barter, P, Mihaylova, B, Mitchel, Y, Blaustein, R, Goto, S, Tobert, J, DeLucca, P, Chen, Y, Chen, Z, Gray, A, Haynes, R, Armitage, J, Baigent, C, Wiviott, S, Cannon, C, Braunwald, E, Collins, R, Bowman, L, Landray, M